The dermatan sulfate-dependent anticoagulant pathway is mostly preserved in aneurysm and in severe atherosclerotic lesions while the heparan sulfate pathway is disrupted

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 906-913

  Tovar, Ana M F ^a   Teixeira, Lisandra A C ^a   Marinho, Ana C O ^b   Pinho, Deborah A ^a   Silva, Luis Felipe ^b   Mourão, Paulo A S ^a  

^a Instituto de Bioquimica Médica and Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anti thrombogenic activity of blood vessel; Chondroitin 4 6 sulfate; Dermatan sulfate; Heparan sulfate; Heparin cofactor II

Indexed keywords

DERMATAN SULFATE; HEPARAN SULFATE; HEPARIN COFACTOR II;

ADOLESCENT; ADULT; AGE; AGED; ANEURYSM; ARTICLE; ATHEROSCLEROSIS; BIOCHEMICAL COMPOSITION; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; TISSUE LEVEL;

ADOLESCENT; ADULT; AGED; AGING; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; BLOOD COAGULATION; DERMATAN SULFATE; HEPARITIN SULFATE; HUMANS; MIDDLE AGED; YOUNG ADULT;

EID: 79955041163     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.01.016     Document Type: Article

References (27)

1. Golledge J., Tsao P.S., Dalman R.L., Norman P.E. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008, 118:2382-2392.
2. Forsdahl S.H., Singh K., Solberg S., Jacobsen B.K. Risk factors for abdominal aortic aneurysms. A 7-year prospective study: the Tromsø Study, 1994-2001. Circulation 2009, 119:2202-2208.
3. Reilly J.M., Tilson M.D. Incidence and etiology of abdominal aortic aneurysms. Surg Clin North Am 1989, 69:705-711.
4. Ernst C.B. Abdominal aortic aneurysm. N Engl J Med 1993, 328:1167-1172.
5. Theocharis A.D., Tsolakis I., Tsegenidis T., Karamanos N.K. Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level. Atherosclerosis 1999, 145:359-368.
6. Theocharis A.D., Theocharis D.A., De Luca G., Hjerpe A., Karamanos N.K. Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurismal dilatation of the human abdominal aorta. Biochimie 2002, 84:667-674.
7. Dobrin P.B., Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurismal dilatation. Cardiovasc Surg 1994, 2:484-488.
8. Campa J.S., Greenhalgh R.M., Powell J.T. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987, 65:13-21.
9. Menashi S., Campa J.S., Greenhalgh R.M., Powell J.T. Collagen in abdominal aortic aneurysm: typing, content and degradation. J Vasc Surg 1987, 6:578-582.
10. Tollefsen D.M. Heparin cofactor II modulates the response to vascular injury. Arterioscler Thromb Vasc Biol 2007, 27:454-460.
11. He L., Giri T.K., Vicente C.P., Tollefsen D.M. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood 2008, 111:4118-4125.
12. Stary H.C., Chandler B., Dinsmore R.E., Fuster V., Glagov S., Insull W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., Wissler R.E. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions Council on Atherosclerosis, American Heart Association. Circulation 1995, 92:1355-1374.
13. Tovar A.M.F., Cesar D.C.F., Leta G.C., Mourão P.A.S. Age-related changes in populations of aortic glycosaminoglycans. Species with low affinity for plasma low-density lipoproteins, and not species with high affinity, are preferentially affected. Arterioscler Thromb Vasc Biol 1998, 18:604-614.
14. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal Biochem 1962, 4:330-334.
15. Leta G.C., Mourão P.A.S., Tovar A.M.F. Human venous and arterial glycosaminoglycans have similar affinity for plasma low density lipoproteins. Biochim Biophys Acta 2002, 1586:243-253.
16. Tovar A.M.F., de Mattos D.A., Stelling M.P., Sarcinelli-Luz B.B.L., Nazareth R.A., Mourão P.A.S. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls. Implications for a possible physiological function of heparin cofactor II. Biochim Biophys Acta 2005, 1740:45-53.
17. de Mattos D.A., Stelling M.P., Tovar A.M.F., Mourão P.A.S. Heparan sulfates from arteries and veins differ in their antithrombin-mediated anticoagulant activity. J Thromb Haemost 2008, 6:1987-1990.
18. Fonseca R.J., Oliveira S.N., Pomin V.H., Mecawi A.S., Araujo I.G., Mourão P.A. Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides. Thromb Haemost 2010, 103:994-1004.
19. Cardoso L.E.M., Mourão P.A.S. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 1994, 14:115-124.
20. Wight T.N., Merrilees M. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 2004, 94:1158-1167.
21. Damus P.S., Hicks M., Rosenberg R.D. Anticoagulant action of heparin. Nature 1973, 246:355-357.
22. Haj Mohammadi S., Enjyoji K., Princivalle M., Christi P., Lech M., Beeler D., et al. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest 2003, 111:989-999.
23. Vicente C.P., He L., Tollefsen D.M. Accelerated atherogenesis and neointima formation in heparin cofactor II-deficient mice. Blood 2007, 110:4261-4267.
24. Aihara K., Azuma H., Akaike M., Ikeda Y., Sata M., Takamori N., et al. Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice. J Clin Invest 2007, 117:1514-1526.
25. Tammi M., Seppala P.D., Lenhtonen A., Mottonen M. Connective tissue components in normal and atherosclerotic human coronary arteries. Atherosclerosis 1978, 29:191-194.
26. Wagner W.D. Proteoglycan structure and function as related to atherosclerosis. Ann NY Acad Sci 1985, 454:52-68.
27. Cattell M.A., Hasleton P.S., Anderson J.C. Glycosaminoglycan content is increased in dissecting aneurysms of human thoracic aorta. Clin Chim Acta 1994, 226:29-46.